American Elements Logo and U.S. Registered Trademark
Ruthenium Iodide
RuI3
13896-65-6
Product
Product Code
Order or Specifications
99% Ruthenium Iodide
RU-I-02
 Contact American Elements
99.5% Ruthenium Iodide
RU-I-025
 Contact American Elements
99.9% Ruthenium Iodide
RU-I-03
 Contact American Elements
99.95% Ruthenium Iodide
RU-I-035
 Contact American Elements
99.99% Ruthenium Iodide
RU-I-04
 Contact American Elements
99.999% Ruthenium Iodide
RU-I-05
 Contact American Elements
Ruthenium Iodide is generally immediately available in most volumes. High purity, submicron and nanopowder forms may be considered. Iodide compounds are used in internal medicine. Treating an iodide with Ruthenium dioxide and sulfuric acid sublimes the iodine. Additional technical, research and safety (MSDS) information is available as is a Reference Calculator for converting relevant units of measurement.

Ruthenium is a Block D, Group 8, Period 5 element. The electronic configuration is [Kr] 4d7 5s1. In its elemental form ruthenium's CAS number is 7440-18-8. The ruthenium atom has a radius of 132.5.pm and it's Van der Waals radius is 200.pm. Ruthenium is member of the platinum group of metals. It is one of the most effective hardeners for platinum and palladium , and is alloyed with these metals to make electrical contacts for severe wear resistanant electronics and laboratory equipment. The corrosion resistance of titanium is improved a hundredfold by addition of 0.1% ruthenium.

Formula CAS No. Appearance Molecular Weight
RuI3 13896-65-6   481.78
PRODUCT CATALOG
News
 Submicron & Nanopowder Tolling Ultra High Purity Sputtering Target Crystal Growth Rod, Plate, Powder, etc.
© 2001-2008. American Elements is a U.S. Registered Trademark. All rights reserved.
This website and all pages, designs, concepts, logos, and color schemes herein are
the copyrighted proprietary rights and intellectual property of American Elements.

 

Recent Research & Development for Ruthenium

  • Architectures based on the use of gold nanoparticles and ruthenium complexes as a new route to improve genosensor sensitivity. Biosens Bioelectron. 2008 Apr 4. [Epub ahead of print]

  • Ruthenium-Olefin Complexes: Effect of Ligand Variation upon Geometry. Chemistry. 2008 May 16. [Epub ahead of print]

  • The aerobic oxidation of alcohols with a ruthenium porphyrin catalyst in organic and fluorinated solvents. Org Biomol Chem. 2008 Jun 7;6(11):1961-5. Epub 2008 Apr 14.

  • Comparison of icilin- and cold-evoked responses of spinal neurones, and their modulation of mechanical activity, in a model of neuropathic pain. Brain Res. 2008 Apr 9. [Epub ahead of print]

  • Triplet Pathways in Diarylethene Photochromism: Photophysical and Computational Study of Dyads Containing Ruthenium(II) Polypyridine and 1,2-Bis(2-methylbenzothiophene-3-yl)maleimide Units. J Am Chem Soc. 2008 May 14. [Epub ahead of print]

  • Facile Concerted Proton-Electron Transfers in a Ruthenium Terpyridine-4'-Carboxylate Complex with a Long Distance Between the Redox and Basic Sites. J Am Chem Soc. 2008 May 14. [Epub ahead of print] No abstract available.

  • Density Functional Theory Study of trans-Dioxo Complexes of Iron, Ruthenium, and Osmium with Saturated Amine Ligands, trans-[M(O)(2)(NH(3))(2)(NMeH(2))(2)](2+) (M=Fe, Ru, Os), and Detection of [Fe(qpy)(O)(2)](n+) (n=1, 2) by High-Resolution ESI Mass Spectrometry. Chemistry. 2008 May 13. [Epub ahead of print]

  • Interaction of Ruthenium(II)-dipyridophenazine Complexes with CT-DNA: Effects of the Polythioether Ancillary Ligands. Met Based Drugs. 2001;8(3):125-36.

  • Construction of Ru(II) Polypyridyl Based Macrocycles: Synthesis, Characterization, Electrochemical, Li Binding, Antitumour and Anti-HIV properties. Met Based Drugs. 2001;8(2):113-7.

  • Studies on Some New Ru(III) Complexes Using aryl-azo Pentane- 2,4-dione and 2,6-bis (2'-Benzimidazolyl) Pyridine as Ligands: Synthesis, Spectroscopic, Luminescent, Electrochemical and Biological Activities. Met Based Drugs. 2001;8(2):65-71.

  • Pharmacological Effects of the Ruthenium Complex NAMI-A Given Orally to CBA Mice With MCa Mammary Carcinoma. Met Based Drugs. 2001;8(1):1-7.

  • Binding of Antitumor Ruthenium(III) Complexes to Plasma Proteins. Met Based Drugs. 2000;7(6):335-42.

  • Reaction of cis- and trans-Dichlorotetra(Dimethylsulfoxide)Ruthenium(II) With the Antiviral Drug Acyclovir. Met Based Drugs. 2000;7(6):325-34.

  • Solvolysis of the Tumor-Inhibiting Ru(III)-Complex trans-Tetrachlorobis(Indazole)Ruthenate(III). Met Based Drugs. 2000;7(4):225-32.

  • Biological Properties of IRIM, the Iridium(III) Analogue of (Imidazolium (Bisimidazole) Tetrachlororuthenate) (ICR). Met Based Drugs. 2000;7(4):195-200.

  • Mitochondria-dependent signalling pathway are involved in the early process of radiation-induced bystander effects. Br J Cancer. 2008 May 13. [Epub ahead of print]

  • Synthesis, structural characteristics, DNA binding properties and cytotoxicity studies of a series of Ru(III) complexes. J Inorg Biochem. 2008 Apr 1. [Epub ahead of print]

  • Ultrathin ruthenium(II) complex-H4SiW12O40 multilayer film. J Nanosci Nanotechnol. 2008 Mar;8(3):1248-53.

  • Chemically-mechanically assisted synthesis of metallic and oxide nanoparticles in ambient conditions. J Nanosci Nanotechnol. 2008 Jan;8(1):386-9.

  • Redox Transformations of Bis(2,2'-bipyridine)(1-methyl-1-pyridin-2-yl-ethylamine)ruthenium(II). Inorg Chem. 2008 May 7. [Epub ahead of print]

 

 

 

 

American Elements Products can also be sourced at these sites:
 
 
 
electronics-ee.com